LSA
PRME icon

Leonteq Securities AG’s Prime Medicine PRME Stock Holding History

Leonteq Securities AG’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-915
Closed -$3.17K – 1450
2025
Q4 		$3.17K Hold
915
– – ﹤0.01% 1288
2025
Q3 		$5.07K Hold
915
– – ﹤0.01% 1165
2025
Q2 		$2.26K Hold
915
– – ﹤0.01% 1170
2025
Q1 		$1.82K Buy
+915
New +$2.33K ﹤0.01% 1152
2023
Q1 		– Sell
-200
Closed -$3.72K – 1300
2022
Q4 		$3.72K Buy
+200
New +$3.61K ﹤0.01% 1158

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Leonteq Securities AG's PRME Position: Q1 2026 in Review

Leonteq Securities AG sold out of Prime Medicine (PRME) in Q1 2026, closing a stake of 915 shares — an estimated $3.17K sold.

Leonteq Securities AG first reported a position in PRME in Q4 2022 and held it in 5 quarters. The position peaked at $5.07K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Leonteq Securities AG reported no remaining Prime Medicine position as of Q1 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 915 Prime Medicine shares in Q1 2026, an estimated $3.17K.
  • Leonteq Securities AG first reported a position in Prime Medicine in Q4 2022 and held it in 5 quarters.
  • Leonteq Securities AG's Prime Medicine position peaked at $5.07K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.